ELITEK® (rasburicase) Plasma Uric Acid Management | Official Site
ELITEK® (rasburicase) Is the first recombinant uricolytic agent approved in the U.S. and is indicated for initial plasma uric acid management.
elitek rasburicase, elitek, rasburicase, tumor lysis syndrome, plasma uric acid, elitek prescribing information
Is this your site? Certify your site and update informations
